Navigation Links
GenVault Corporation Launches GenTegra(TM) DNA

Proprietary inorganic matrix for dry state room temperature transport and

storage of purified DNA

CARLSBAD, Calif., Oct. 8 /PRNewswire/ -- GenVault Corporation, the leader in dry, room temperature biosample management, announces the launch of an innovative new product, GenTegra(TM) DNA. GenTegra DNA is a proprietary inorganic matrix with built-in oxidative protection and antimicrobial activity for dry, room temperature transport and storage of purified DNA. GenTegra DNA is provided in ready to use aliquots, and purified DNA dried within GenTegra DNA is simply and fully resolubilized with water for direct downstream molecular analysis.

"GenVault's goal is to provide solutions that enable efficiency in biosample management for genomic-based medicine and research. GenTegra DNA is the first of GenVault's next generation of core innovative technologies that will include a broad range of sample types," said David Wellis, Ph.D., CEO of GenVault.

"Our goal at the Eccles Institute of Human Genetics of developing rapid and large-scale genotyping techniques for identifying genetic variations that confer predispositions to human disorders and traits is well served by innovative technologies such as GenTegra(TM) DNA. Preservation of DNA integrity in a dry state room temperature environment such as GenTegra benefits large scale studies and any worldwide genomic community efforts," said Dr. Mark F. Leppert, Ph.D, Professor and Co-Chair, Department of Human Genetics, University of Utah.

"Our work at Scripps Translational Science Institute benefits from innovative technologies such as GenTegra(TM) for storing and transporting DNA samples with our collaborators. The genotyping results of frozen samples and samples stored with GenTegra at room temperature were identical, indicating that recovered samples were of high purity and quality," said Sarah Shaw Murray, Ph.D., Director of Genetics, Scripps Genomic Medicine, The Scripps Translational Science Institute.

"Wildlife species conservation efforts are impacted by improvements in genetic testing and management of increasing numbers of purified DNA samples. GenTegra(TM) DNA Tubes provide an innovative method of storing DNA safely at room temperature. DNA integrity is preserved and pure, high molecular weight DNA is easily recovered for immediate use in downstream applications. Current and future studies in our laboratory on large mammals from North America and Africa will benefit from innovative storage and shipping solutions such as GenTegra DNA," said Natalie Halbert, Ph.D, Research Assistant Professor, Conservation Genetics and Genomics, Texas A&M University.

"Our collaborative initiatives will benefit a great deal from innovative technologies like GenTegra, especially in sharing and storage of biosamples from global cohorts. We were pleased with the high yield and quality of the DNA that we recovered from the GenTegra DNA tubes," said Maurine Hobbs, Ph.D., Assistant Professor, Division of Infectious Diseases at the University of Utah.

Maintaining DNA integrity as well as simplifying laboratory workflows is no longer a concern with long term storage at room temperature. GenTegra(TM) DNA ensures sample stability and is compatible with the most demanding molecular assays. GenTegra along with the full suite of GenVault products provide smart, environmentally and financially sustainable solutions which complement and enhance existing cryostorage systems.

For more information on GenTegra DNA, please visit our GenTegra DNA webpage at:

About GenVault

GenVault is the global leader in providing biosample workflow, transport, and storage solutions for genomic medicine, discovery and identification. Today, GenVault is empowering over 150 pharmaceutical companies, medical centers, academic institutions and law enforcement agencies to more fully leverage the rapidly growing genomics industry. As a scalable and reliable complement to traditional freezers and DNA purification systems, the company's dry state platform enables the extraction, preservation, recovery, and distribution of DNA at room temperature. Future systems will accommodate proteins and RNA to provide a comprehensive solution. From the GenPlate to the Dynamic Archive, GenVault is continuously developing and refining best practices for biomolecule sample management and preservation. For more information visit GenVault at .


Rene Nunez, Senior Product Marketing Manager

GenVault Corporation

(760) 268-5200

SOURCE GenVault Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. GenVault Expands Scientific Advisory Board
2. Paul J. Mirabella, President and CEO of Naviscan PET Systems Inc., Joins GenVaults Board of Directors
3. Mark Ostrowski Joins GenVault as Vice President of Sales and Marketing
4. McGill University Purchases GenVaults Personal Archive System to Manage Rare Cancer Samples
5. GenVault and the National Center for Forensic Science to Present Novel Technology for Room Temperature Storage of RNA
6. David Barker, Former Illumina CSO, Joins GenVaults Scientific Advisory Board
7. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
8. AMERIGROUP Corporation to Discuss Third Quarter Earnings on October 23
9. Environmental Tectonics Corporation Announces the Placement of Two Monoplace Hyperbaric Chambers at Saint Barnabas Medical Center in New Jersey
10. Alba Therapeutics Corporation Announces Promotions
11. Verenium Corporation to Present at the William Blair & Company 2008 Small-Cap Growth Stock Conference
Post Your Comments:
(Date:11/24/2015)... QUEBEC CITY , Nov. 24, 2015 /PRNewswire/ - ... the request of IIROC on behalf of the Toronto ... this news release there are no corporate developments that ... price. --> --> ... --> . --> Aeterna Zentaris ...
(Date:11/24/2015)... Muncie, IN (PRWEB) , ... November 24, 2015 , ... ... its newest Special Interest Group (SIG), MultiGP, also known as Multirotor Grand Prix, to ... in the last few years. Many AMA members have embraced this type of racing ...
(Date:11/24/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) ... remaining 11,000 post-share consolidation (or 1,100,000 pre-share consolidation) ... B Warrants") subject to the previously disclosed November ... 2015, which will result in the issuance of ... the issuance of such shares, there will be ...
(Date:11/24/2015)... ... November 24, 2015 , ... Creation Technologies would ... named to Deloitte's 2015 Technology Fast 500 list of the fastest growing companies ... FDA-cleared, Class II medical device that speeds up orthodontic tooth movement by as ...
Breaking Biology Technology:
(Date:11/16/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), ... announced expansion of its TDDI product portfolio with ... and display driver integration (TDDI) solutions designed to ... TDDI products add to the previously-announced TD4300 ... resolution), and TD4322 (FHD resolution) solutions. All four ...
(Date:11/11/2015)... 11, 2015   MedNet Solutions , an innovative SaaS-based ... research, is pleased to announce that it will be a ... event, to be held November 17-19 in ... live demonstrations of iMedNet , MedNet,s easy-to-use, ... iMedNet has been able to deliver time and cost ...
(Date:11/9/2015)... , Nov. 9, 2015  Synaptics Inc. (NASDAQ: ... today announced broader entry into the automotive market with ... match the pace of consumer electronics human interface innovation. ... are ideal for the automotive industry and will be ... Europe , Japan ...
Breaking Biology News(10 mins):